According to the materials of the Conference “Algorithms of emergency situations in oncohematology. Approaches and treatment”

Cover Page

Cite item

Full Text

Abstract

В Онкологическом центре Клинического госпиталя «Лапино» группы компаний «Мать и дитя» 10 сентября 2021 г. состоялась конференция, посвященная тактике ведения пациентов с онкогематологическими заболевани ями в ургентных клинических ситуациях.

На конференции с докладами выступили не только ведущие российские онкологи и гематологи, но и врачи других специальностей (по поддерживающей терапии, инструментальной диагностике, анестезиологи-реаниматологи, акушеры-гинекологи, патоморфологи).

Были освещены самые актуальные вопросы диагностики и лечения пациентов в тех случаях, когда незамедлительная правильно выбранная тактика может способствовать благоприятному прогнозу.

About the authors

Yu. E. Ryabukhina

Клинический госпиталь «Лапино» группы компаний «Мать и дитя»

Author for correspondence.

Кандидат медицинских наук, врач-гематолог, онколог.

Russian Federation

References

  1. Video recording of the conference broadcast on the https://innovizion.ru/gematology website and YouTube Innovizion channel. (In Russ.).
  2. Bataille B., Delwail V., Menet E. et al. Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 2000;92(2):261-6. doi: 10.3171/jns.2000.92.2.0261
  3. Villano J.L., Koshy M., Shaikh H. et al. Age, gender, and racial differences in incidence and survival in primary CNS lymphoma. Br J Cancer 2011;105(9):1414—8. doi: 10.1038/bjc.2011.357
  4. Fotiou D., Dimopoulos M.A., Kastritis E. Managing renal complications in multiple myeloma. Expert Rev Hematol 2016;9(9):839—50. doi: 10.1080/17474086.2016.1210003
  5. Young N.A., Al-Saleem T. Diagnosis of lymphoma by fine-needle aspiration cytology using the revised European-American classification of lymphoid neoplasms. Cancer 1999;87(6):325-45. doi: 10.1002/(sici)1097-0142(19991225)87:6<325::aid-cncr3>3.0.co;2-w
  6. Pauken K.E., Dougan M., Rose N.R. et al. Adverse events following cancer immunotherapy: obstacles and opportunities. Trends Immunol 2019;40(6):511-23. doi: 10.1016/j.it.2019.04.002
  7. Naidoo J., Wang X., Woo K.M. et al. Pneumonitis in patients treated with antiprogrammed death-1/programmed death ligand 1 therapy. J Clin Oncol 2017;35(7):709-17. doi: 10.1200/JCO.2016.68.2005
  8. Friedman C.F., Proverbs-Singh T.A., Postow M.A. Treatment of the immune-related adverse effects of immune checkpoint inhibitors: a review. JAMA Oncol 2016;2(10):1346-53. doi: 10.1001/jamaoncol.2016.1051
  9. Buemi M., Fazio M.R., Bolignano D. et al. Renal complications in oncohe-matologic patients. J Investig Med 2009;57(8):892-901. doi: 10.2310/JIM.0b013e3181c5e762
  10. Gromova E.G., Biryukova L.S., Dzhumabaeva B.T., Kurmukov I.A. Practical recom mendations for the correction of anticancer drugs nephrotoxicity. Zlokachestvennye opukholi: Prakticheskie rekommendatsii RUSSCO = Malignant Tumors: RUSSCO Practical Guidelines 2020;10(3s2):133-45. (In Russ.). doi: 10.18027/2224-5057-2020-10-3s2-46
  11. Dimopoulos M.A., Sonneveld P., Leung N. et al. International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment. J Clin Oncol 2016;34(13):1544-55. doi: 10.1200/JCO.2015.65.0044
  12. Ozcan A., Unal E., Karakukcu M. et al. Vena cava superior syndrome in the children with mediastinal tumors: single-center experience. North Clin Istanb 2020;7(3):255-9. doi: 10.14744/nci.2019.46354
  13. Ferreri A.J., Reni M., Pasini F. et al. A multicenter study of treatment of primary CNS lymphoma. Neurology 2002;58(10):1513-20. doi: 10.1212/wnl.58.10.1513
  14. Iwamoto F.M., DeAngelis L.M., Abrey L.E. Primary dural lymphomas: a clinicopathologic study of treatment and outcome in eight patients. Neurology 2006;66(11):1763-5. doi: 10.1212/01.wnl.0000218284.23872.eb
  15. Zucca E., Conconi A., Pedrinis E. et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 2003;101(7):2489-95. doi: 10.1182/blood-2002-04-1279
  16. Gubkin A.V., Zvonkov E.E., Kremenetskaya A.M., Kravchenko S.K. Primary lymphoproliferative diseases of the central nervous system. Klinicheskaya onkogematologiya. Fundamental'nye issledovaniya i klinicheskaya praktika = Clinical Oncohematology. Basic Research and Clinical Practice 2008;1(4):323—32. (In Russ.).
  17. Perez-Soler R., McLaughlin P., Velasquez W.S. et al. Clinical features and results of management of superior vena cava syndrome secondary to lymphoma. J Clin Oncol 1984;2(4):260-6. doi: 10.1200/JCO.1984.2.4.260
  18. Singleton J.M., Hefner M. Spinal Cord Compression. StatPearls Publishing, 2021.
  19. Rades D., Stalpers L.J.A., Veninga T. et al. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol 2005;23(15):3366-75. doi: 10.1200/JCO.2005.04.754
  20. Balducci M., Chiesa S., Rossi E. et al. Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience. Strahlenther Onkol 2011;187(2):114-9. doi: 10.1007/s00066-010-2155-9
  21. Rudzianskiene M., Inciura A., Gerbutavicius R. et al. Single vs. multiple fraction regimens for palliative radiotherapy treatment of multiple myeloma: a prospective randomised study. Strahlenther Onkol 2017;193(9):742-9. doi: 10.1007/s00066-017-1154-5
  22. De Haan J., Verheecke M., van Calsteren K. et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. Lancet Oncol 2018;19(3):337-46. doi: 10.1016/S1470-2045(18)30059-7
  23. Vinokurov A.A. Hodgkin's lymphoma and reproductive problems in men. Klinicheskaya onkogematologiya. Fundamental'nye issledovaniya i klini-cheskaya praktika = Clinical Oncohe-matology. Basic Research and Clinical Practice 2013;6(3):258-73. (In Russ.).
  24. Meistrich M.L., Vassilopoulou-Sellin R., Lipshultz L.I. Adverse effects of treatment: gonadal dysfunction. 7th edn. Philadelphia: Lippincott Williams & Wilkins, 2005.
  25. Einsele H., Bertz H., Beyer J. et al. Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies -guidelines of the Infectious Disease Working Party (AGIHO) of German Society of Hematology and Oncology (DGHO). Ann Hematol 2003;82(Suppl 2) 175-85. doi: 10.1007/s00277-003-0772-4
  26. Gratwohl A., Baldomero H., Horisberger B. et al. Current trends in hematopoietic stem cell transplantation in Europe. Blood 2002;100(6):2374-86. doi: 10.1182/blood-2002-03-0675
  27. Vavilov V.N., Averyanova M.Yu., Bondarenko S.N. et al. Bacterial infections in the early period after allogeneic bone marrow transplantation. Terapevticheskii arkhiv = Terapeutic Archive 2017;87(7):88-93. (In Russ.). doi: 10.17116/terarkh201587788-93
  28. Park S.H., Choi S.M., Lee D.G. et al. Current trends of infections following hematopoietic stem cell transplantation in a single center. J Korean Med Sci 2006;21(2):199-207. doi: 10.3346/jkms.2006.21.2.199
  29. Kikuchi M., Akahoshi Y., Nakano H. et al. Risk factors for pre and postengraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2015;17(1):56-65. doi: 10.1111/tid.12345
  30. Akhmedov M.I., Klyasova G.A., Parovichnikova E.N. et al. Bloodstream infections in different stage of reconstitution after first allogeneic hematopoietic stem cell transplantation. Onkogematologiya = Oncohematology 2022;17(1):121-34. (In Russ.). doi: 10.17650/1818-8346-2022-17-1121-134
  31. Ryabukhina Yu.E., Abbasbeyli F.M., Zeynalova P.A. et al. Modern approaches to the treatment of relapsed follicular lymphoma. Onkogematologiya = Oncohematology 2022;17(3):24-30. (In Russ.). doi: 10.17650/1818-8346-2022-17-3-24-30

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c)


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-36928 от  21.07.2009.